Dopamine receptor antagonists.

Area of Science:

• Pharmacology
• Clinical Medicine
• Gastroenterology

Background:

• Intractable nausea and/or vomiting significantly impacts patient quality of life.
• Dopamine receptor antagonists are a primary class of antiemetic medications.
• Current clinical practice may involve switching between dopamine antagonists for refractory symptoms.

Purpose of the Study:

• To evaluate the efficacy of switching versus adding antiemetic agents.
• To explore optimal therapeutic strategies for intractable nausea and vomiting.

Main Methods:

• Review of antiemetic prescribing patterns.
• Analysis of treatment outcomes for different antiemetic regimens.

Main Results:

• Dopamine receptor antagonists are frequently used but may not always be effective.
• Clinicians sometimes switch between dopamine antagonists rather than adding other classes.

Conclusions:

• Consideration of alternative antiemetic classes (e.g., 5-HT3, NK-1 antagonists) is crucial when dopamine antagonists fail.
• Optimizing antiemetic therapy requires exploring combination strategies beyond dopamine receptor antagonist monotherapy.